Status:

COMPLETED

Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney Transplantation

Lead Sponsor:

University of Miami

Collaborating Sponsors:

Wyeth-Ayesrst Pharmaceuticals, Roche Laboratories, and Fujusawa Healthcare, Inc.

Conditions:

Adult Primary Kidney Transplantation

Eligibility:

All Genders

16+ years

Phase:

PHASE4

Brief Summary

Comparison of outcomes/safety/and tolerability of SRL/FK/Pred vs. FK/MMF/Pred vs. SRL/Neoral®/Pred in cadaveric and non-HLA identical LRD kidney transplants.

Eligibility Criteria

Inclusion

  • Age \>14 years
  • Weight \> 40 kg
  • Primary renal allograft: cadaveric or mismatched living donor
  • Negative standard cross match for T-cells
  • Women of childbearing potential will be required to have a negative qualitative serum pregnancy test and agree to use an adequate method of contraception throughout the study period and for 3 months after discontinuation of study medication (3yrs, 3 mos.)
  • Signed and dated informed consent (Parent or legal guardian must provide written consent for patients \<18 years of age)

Exclusion

  • Evidence of systemic infection
  • History of malignancy within 10 years (with the exception of localized skin cancer)
  • Use of any investigational drug or treatment up to 4 weeks prior to enrolling in the study and during the 12-month treatment phase
  • Concurrent use of astemizole, pimozide, cisapride, terfenadine, or ketoconazole
  • Known hypersensitivity to sirolimus and its derivatives
  • Patients with a screening/baseline (or within 96 hours of transplant)
  • total white blood cell count \< 4000/mm3;
  • platelet count \< 100,000/mm3;
  • fasting triglycerides \> 400 mg/dl (\> 4.6 mmol/L);
  • fasting total cholesterol \> 300 mg/dl (\> 7.8 mmol/L);
  • fasting HDL-cholesterol \< 30 mg/dl;
  • fasting LDL-cholesterol \> 200mg/dl

Key Trial Info

Start Date :

May 1 2000

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2002

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT00681213

Start Date

May 1 2000

End Date

December 1 2002

Last Update

September 22 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Miami Division of Transplantation

Miami, Florida, United States, 33136